Fenoldopam hydrobromide structure
|
Common Name | Fenoldopam hydrobromide | ||
|---|---|---|---|---|
| CAS Number | 67287-54-1 | Molecular Weight | 386.66800 | |
| Density | 1.38g/cm3 | Boiling Point | 522.6ºC at 760 mmHg | |
| Molecular Formula | C16H17BrClNO3 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 269.9ºC | |
| Symbol |
GHS07, GHS08 |
Signal Word | Danger | |
| Name | Fenoldopam monohydrobromide |
|---|---|
| Synonym | More Synonyms |
| Density | 1.38g/cm3 |
|---|---|
| Boiling Point | 522.6ºC at 760 mmHg |
| Molecular Formula | C16H17BrClNO3 |
| Molecular Weight | 386.66800 |
| Flash Point | 269.9ºC |
| Exact Mass | 385.00800 |
| PSA | 72.72000 |
| LogP | 4.02130 |
| Symbol |
GHS07, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H317-H319-H334 |
| Precautionary Statements | P261-P280-P305 + P351 + P338-P342 + P311 |
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Faceshields;Gloves |
| Hazard Codes | Xn |
| Risk Phrases | R22;R36;R42/43 |
| Safety Phrases | S22;S26;S36/S37/S39 |
| RIDADR | NONH for all modes of transport |
| Precursor 10 | |
|---|---|
| DownStream 1 | |
|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Nat. Chem. Biol. 3(5) , 268-273, (2007) The identification of self-renewing and multipotent neural stem cells (NSCs) in the mammalian brain holds promise for the treatment of neurological diseases and has yielded new insight into brain canc... |
|
|
Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum.
Nat. Chem. Biol. 5 , 765-71, (2009) Studies of gene function and molecular mechanisms in Plasmodium falciparum are hampered by difficulties in characterizing and measuring phenotypic differences between individual parasites. We screened... |
|
|
Contrast-induced nephropathy: protective role of fenoldopam.
Clin. Exp. Pharmacol. Physiol. 39(6) , 497-505, (2012) 1. Contrast-induced nephropathy (CIN) often occurs after contrast media-related procedures and is associated with increased morbidity and mortality. The acute renal failure observed after administrati... |
| EINECS 266-634-7 |
| 9-chloro-5-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol,hydrobromide |